Hossein Mokhtari

Hossein Mokhtari

Auto-generated profile, based on publicly available information

Hossein Mokhtari

Immunogenetic Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
SDSima Davoodi
Sima Davoodi
RERoohollah Ebrahimpour‐Malekshah
Roohollah Ebrahimpour‐Malekshah
ÖAÖmer Ayna
Ömer Ayna
MAMitra Akbari
Mitra Akbari
ARAmir Raoofi
Amir Raoofi
DNDavood Nasiry
Davood Nasiry

6 September 2016 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
MRMehdi Rasouli
Mehdi Rasouli
HMHossein Mokhtari
Hossein Mokhtari
Background: Low‐density lipoprotein cholesterol (LDLc) can be calculated or measured directly and their accordance is the subject of controversy.Objectives: The aim of this study was to identify the independent predictors of LDLc, to formulate the best equation for calculating LDLc and to evaluate the validity of it and the published formulas, including the new method with adjustable coefficient.Methods: The profile of serum lipids and (apo)lipoproteins of 310 subjects was used to determine the most accurate formula for calculating serum LDLc. Serum lipids, lipoproteins and apolipoproteins were measured by enzymatic, new homogenous and immunoturbidometric methods, respectively.Results: Multiple linear regression analysis indicates that total cholesterol, apoB, HDLc and triglyceride are independent predictors of LDLc. We proposed four new formulas to calculate LDLc. As total cholesterol (TC) is the major determinant of LDLc, it can be estimated simply as 0.545 of total cholesterol. Inclusion of HDLc, triglyceride, apoB and a constant value improved the equation slightly. The equation of: LDLc (mg/dl) = 0.75 TC − 0.5 HDLc − 0.1 TG had the lowest mean and SD of difference among all the methods examined here. LDLc was also calculated by the new modified Friedewald's equation using adjustable factor from Martin's table, but it did not improve the results significantly. LDLc gap was correlated significantly and positively with triglyceride and negatively with cholesterol or its subfractions.Conclusions: Our data suggest the simplest formula: LDLc = 0.545 TC or a more detailed: LDLc = 0.75 TC − 0.5 HDLc − 0.1 TG be used for calculating serum LDLc.

27 December 2022 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Closed access
NBNadereh Bakhshandeh
Nadereh Bakhshandeh
MMMaryam Mohammadi
Maryam Mohammadi
PMParisa Mohammadi
Parisa Mohammadi
ENElahe Nazari
Elahe Nazari
MDMehdi Damchi
Mehdi Damchi
HMHossein Mokhtari
Hossein Mokhtari
Objectives: Androgen receptor (AR) play a key role in the onset and progression of prostate cancer. Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound and the active ingredient in green tea, which is involved in modulating gene expression through epigenetic alterations. Previous studies have shown that EGCG at low concentrations reduces the expression of AR and prostate-specific antigen (PSA) in the LNCaP cell line of prostate cancer. In this study, the effect of higher EGCG concentrations on AR and PSA expression in LNCaP prostate cancer cell line was investigated. Methods: In this study, LNCaP prostate cancer cell line was used and after MTT test, concentrations of 40, 60 and 80 μg/mL EGCG were used for treatment. Then, the expression of AR and PSA genes was evaluated by RT-PCR. AR protein expression was also assessed by Western blotting. Results: The present study showed that treatment of LNCaPs cells by EGCG reduces cell proliferation. The IC50 value was 42.7 μg/mL under experimental conditions. It was also observed that EGCG at concentrations of 40 and 80 μg/mL increased the expression of AR and PSA (p<0.05). Conclusions: The present study showed that the effect of EGCG on AR expression was different at different concentrations, so that unlike previous studies, higher concentrations of EGCG (80 and 40 μg/mL) increased AR and PSA expression. It seems that due to the toxic effects of EGCG in high concentrations on cancer cells and the possibility of its effect on normal cells, more caution should be exercised in its use.

1 October 2023 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
MHMohsen Hemmati-Dinarvand
Mohsen Hemmati-Dinarvand
HMHossein Mokhtari
Hossein Mokhtari
Iraj AlipourfardIraj Alipourfard
Iraj Alipourfard
EAElham Beyrami Aghbash
Elham Beyrami Aghbash
SKShahnaz Kheirandish
Shahnaz Kheirandish
ASAtefeh Seghatoleslam
Atefeh Seghatoleslam
Object(s): Shortly after cancer is diagnosed, a phenomenon develops in cancer cells called multidrug resistance (MDR), in which cell sensitivity against anti-cancer drugs is significantly reduced. The present investigation aimed to assess the effects of nitazoxanide (NTZ), a safe drug, on LS174T/OXP-resistant cells. Methods: In the current in vitro research, the effects of NTZ and oxaliplatin (OXP) on the viability of LS174T and LS174T/OXP cell lines were evaluated through MTT assay. Then, the changes in expression levels of MDR1, MRP1, BCRP, and LRP genes and proteins were measured by RT-qPCR and western blotting methods, respectively. Lastly, the apoptosis status was assessed by annexin V–FITC/PI staining flow cytometry assay. Results: The IC50 values for cells resistant or sensitive to OXP were revealed (11567 nM vs. 1745 nM; p <0.05 for 24 h incubation, and 5161 nM vs. 882.2 nM; p <0.05 for 48 h incubation). Moreover, NTZ plus OXP led to a leftward shift in the cytotoxicity curve (2004 nM; p = 0.007). This co-treatment significantly decreased the expression of all genes and proteins (p <0.05). Finally, the combination of NTZ and OXP induced a significant increase in apoptosis (p <0.001). Conclusion: The data showed that NTZ treatment could increase the sensitivity of LS174T/OXP cell line to the OXP cytotoxic effects. Thus, NTZ may be efficient in reducing drug resistance in clinics by means of the negative regulation of ATP-binding cassette (ABC) transporters. However, further studies are necessary to explain the exact mechanisms of NTZ.